Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 26, 2022; 10(33): 12184-12199
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12184
Table 3 Assessment of quality of life, anxiety and depression, and self-esteem of patients with inflammatory bowel disease

IBD (n = 133)
Crohn’s disease (n = 69)
Ulcerative colitis (n = 64)
P value2
Quality of life (IBDQ)1, n (%)0.0469
Excellent25 (18.94)12 (17.65)13 (20.31)
Good60 (45.45)38 (55.88)22 (34.38)
Regular32 (24.24)14 (20.59)18 (28.13)
Poor15 (11.36)4 (5.88)11 (17.19)
IBDQ score (points)
Bowel function52.61 ± 13.6255.21 ± 11.4949.84 ± 15.180.0427
Systemic symptoms22.17 ± 7.1923.12 ± 7.2521.16 ± 7.050.1177
Social function26.62 ± 8.2227.51 ± 7.6725.67 ± 8.720.2653
Emotional status58.34 ± 16.8460.88 ± 14.9655.64 ± 18.360.0737
Total score159.73 ± 42.72166.72 ± 38.56152.31 ± 45.880.0524
SF-36 (points)
Physical aspects60.34 ± 42.7764.49 ± 40.3155.86 ± 45.150.5028
Physical function72.22 ± 29.3177.90 ± 24.7866.09 ± 32.620.1216
Bodily pain49.70 ± 8.3450.00 ± 8.9149.38 ± 7.740.6677
General health54.66 ± 19.6756.16 ± 19.0253.05 ± 20.370.3638
Mental health60.12 ± 22.0764.64 ± 21.3555.25 ± 21.950.0137
Vitality52.44 ± 22.7856.01 ± 22.8648.59 ± 22.230.0602
Emotional aspects60.15 ± 43.9063.29 ± 42.0656.77 ± 45.880.5176
Social function47.37 ± 15.2449.82 ± 14.4644.73 ± 15.720.0538
SF-36 total score57.13 ± 18.0960.29 ± 17.3653.71 ± 18.390.0511
Presence of anxiety, n (%)53 (40.46)21 (30.88)32 (50.79)0.0203
Presence of depression, n (%)38 (29.01)19 (27.94)19 (30.16)0.7799
Anxiolytic and antidepressant use, n (%)31 (23.30)12 (17.39)19 (29.69)0.0938
Psychological monitoring, n (%)21 (15.79)5 (7.25)16 (25.0)0.0050
Self-esteem scale, n (%)0.5120
Low self-esteem5 (3.76)2 (2.90)3 (4.69)
Medium self-esteem19 (14.29)12 (17.39)7 (10.94)
High self-esteem109 (81.95)55 (79.71)54 (84.38)
Routine limitation by IBD, n (%)65 (48.87)31 (44.93)34 (53.31)0.3447
Trust in medical treatment, n (%)119 (89.47)63 (91.30)56 (87.50)0.4750